glp-1 obesity cardiovascular news drugs are changing more than the number on the scale. From diabetes and to heart, kidney, and metabolic health — this story is getting bigger fast. ❤️ Swipe to learn Semaglutide Shows Secondary Cardiovascular Prevention

To expand our knowledge of the underlying molecular mechanism of OsDHAR activity against ROS, high-resolution crystal structures of the apo-form, AsA-bound and GSH-bound OsDHAR were examined at 1.9, 1.7 and 1.7 resolution, respectively

Agents such as semaglutide and liraglutide, which have relatively low molecular weights, can cross the blood-brain barrier via GLP-1 receptors expressed on ependymal cells lining the ventricles

The researchers concluded, " The presence of a GHK triplet in the alpha 2(I) chain of type I collagen suggests that the tripeptide might be liberated by proteases at the site of a wound and exert in situ healing effects

1167A, Road No

medRxiv 2023